We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...
The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual Summit of Biologics Conference and Workshops focused on Biopharmaceutical ...
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
Commvault, a pioneering provider of cyber resilience and data protection solutions for the hybrid cloud, announced that the Commvault Cloud Platform can be easily deployed from major ...
Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.
Growing demand for tryptamine APIs stems from their anti-cancer potential, pharmaceutical uses, and role as a neurotransmitter modulator i ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...
Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.
Behind Winrevair, though, there isn't much in Merck's pipeline to get excited about. Behind Winrevair, the most promising clinical-stage program in Merck's pipeline is a cholesterol drug ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results